
## **Trustees’ Annual Report for the period** 

**From 1 January 2021              To 31 December 2021** 

**Charity name: Arrhythmogenic Cardiomyopathy Trust** 

## **Charity registration number: 1176790** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|TO PROMOTE AND PROTECT GOOD<br>HEALTH FOR THE PUBLIC BENEFIT,<br>RELATING TO INHERITED HEART<br>CONDITIONS AND IN PARTICULAR<br>ARRYTHMOGENIC CARDIOMYOPATHY<br>BY FUNDING RESEARCH PROJECTS,<br>SUCH PROJECTS CAN BE<br>DIAGNOSTIC, CURATIVE,<br>THERAPEUTIC OR PALLIATIVE IN<br>NATURE AND TO ENSURE THE<br>PUBLICATION OF THE USEFUL<br>RESULTS OF SUCH RESEARCH.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|Further fundraising. Grant made to UCL<br>for project “A Clinical and Molecular<br>Platform for Disease Stratifcation in<br>Arrhythmogenic Cardiomyopathy” - frst of<br>two tranches of funding, the second of<br>which was made in 2022.|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|This guidance has been noted by the<br>trustees of the charity.|



**Achievements and Performance** 



||SORP reference<br>Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.<br>Para 1.20<br>During the year, the charity has<br>successfully raised a further £48,591 to<br>support its objectives of funding medical<br>research projects focussed on<br>Arrhythmogenic Cardiomyopathy, a heart<br>muscle disease that affects young people.<br>This means that the charity has raised<br>almost £150,000 to achieve its objectives.<br>After reaching an agreement with UCL in<br>November 2020 to fund a project titled<br>‘Disease Stratifcation in Arrhythmogenic<br>Cardiomyopathy,’ we were pleased to see<br>the project commence as planned during<br>2021, for which the charity made a frst<br>tranche payment of £57,651.|
|---|---|





## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|The charity had cash reserves of £77,871 at<br>year end. The charity holds only cash<br>deposits, with no debt.|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|Reserves will be held on an ongoing basis<br>until a research project is successfully<br>funded.|
|Amount of reserves held|Para 1.22|£77,871|
|Reasons for holding zero<br>reserves|Para 1.22|n/a|
|Details of fund materially in<br>deficit|Para 1.24|n/a|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|No concerns|





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|<br>Para 1.25|CIO governing document|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|CIO|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Trustees appointed by resolution of existing<br>trustees|



## **Reference and Administrative details** 

|Charity name|Arrhythmogenic Cardiomyopathy Trust|
|---|---|
|Other name the charity uses|ACT|
|Registered charity number|1176790|
|Charity’s principal address|97 Rosebank, Holyport Road, London SW6 6LJ|
|||





**Names of the charity trustees who manage the charity** 

||**Trustee name**|**Office (if any)**|**Dates acted if not for**<br>**whole year**|**Name of person (or body)**<br>**entitled to appoint trustee**<br>**(if any)**|
|---|---|---|---|---|
|1 <br>2 <br>3 <br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|James Minch|Trustee|||
||Kate Minch|Trustee|||
||Rachel Bailey|Trustee|||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



Corporate trustees – names of the directors at the date the report was approved 

## **Director name** 

Name of trustees holding title to property belonging to the charity 

**Dates acted if not for whole year** 

**Trustee name** 



**Funds held as custodian trustees on behalf of others** 

|Description of the assets<br>held in this capacity|n/a|
|---|---|
|Name and objects of the<br>charity on whose behalf the<br>assets are held and how this<br>falls within the custodian<br>charity’s objects|n/a|
|Details of arrangements for<br>safe custody and<br>segregation of such assets<br>from the charity’s own assets|n/a|



## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

## **Other optional information** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees Signature(s) Full name(s)** James Minch Rachel Bailey **Position (eg** Trustee Trustee **Secretary, Chair, etc) Date** 30.10.22 



||**Arrhythmogenic Cardiomyopathy Trust**|**Arrhythmogenic Cardiomyopathy Trust**|**Arrhythmogenic Cardiomyopathy Trust**|**Arrhythmogenic Cardiomyopathy Trust**|**Arrhythmogenic Cardiomyopathy Trust**|**No(if any)**|**No(if any)**||
|---|---|---|---|---|---|---|---|---|
||||||||||
||**Receipts andpayments accounts**||||||||
||**For the period**<br>**from**||01/01/2021||**To**||31/12/2021||
||||||||||
||||||||||
|**Section A Receipts and payments**|||||||||
||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**||**Total funds**||
||**to the nearest      £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||
|**A1 Receipts**|||||||||
|Income|**48,591**||**-**||**-**||**48,591**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
|**_Sub total_**_(Gross income for AR) _|<br>**48,591**||**-**||**-**||**48,591**||
||||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||||
||**- 0**||**- 0**||**- 0**||**-**||
||**- 0**||**- 0**||**- 0**||**-**||
|**_Sub total _**|<br>**- 0**||**- 0**||**- 0**||**-**||
||||||||||
|**_Total receipts_ **|<br>**48,591**||**- 0**||**- 0**||**48,591**||
||||||||||
|**A3 Payments**|||||||||
|Expenses|**562**||**-**||**-**||**562**||
|Grants made|**57,651**||**-**||**-**||**57,651**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
|**_Sub total_ **|<br>**58,213**||**-**||**-**||**58,213**||
||||||||||
|**A4 Asset and investment**<br>**purchases,(see table)**|||||||||
||**- 0**||**- 0**||**- 0**||**-**||
||**- 0**||**- 0**||**- 0**||**-**||
|**_Sub total_ **|<br>**-0**||**-0**||**-0**||**-**||
||||||||||
|**_Totalpayments_ **|<br>**58,213**||**- 0**||**- 0**||**58,213**||
||||||||||
|**_Net of receipts/(payments)_ **|**-**<br>**9,622**||**-**||**-**||**-**<br>**9,622**||
|**A5 Transfers between funds**|**- 0**||**-**||**-**||**-**||
|**A6 Cash funds lastyear end**|**87,493**||**-**||**-**||**87,493**||
|**_Cash funds thisyear end_ **|<br>**77,871**||**-**||**-**||**77,871**||
||||||||||
||||||||||
|**Section B Statement of assets and liabilities at the end of the period**|||||||||
|**Categories**|**Details**||||**Unrestricted**<br>**funds**||**Restricted funds**||
||||||**to nearest £**||**to nearest £**||
|**B1 Cash funds**|||||**77,871**||**-**||
||||||**-**||**-**||



CCXX R1 accounts (SS) 

31/10/2020 

1 



||||||**-**||**-**||
|---|---|---|---|---|---|---|---|---|
||**_Total cash funds_**||||**77,871**||**-**||
||(agree balances with receipts and payments<br>account(s))||||OK||||
||||||**Unrestricted**<br>**funds**||**Restricted funds**||
||**Details**||||**to nearest £**||**to nearest £**||
|**B2 Other monetary assets**|||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||||||
||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||
|**B3 Investment assets**|||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||||
||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||
|**B4 Assets retained for the**<br>**charity’s own use**|||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||||
||**Details**||||**Fund to which**<br>**liability relates**||**Amount due**<br>**(optional)**||
|**B5 Liabilities**|||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||||
|Signed by one or two trustees on behalf<br>of all the trustees|Signature||||Print Name||||
||||||James Minch||||
||||||||||
||||||||||



CCXX R2 accounts (SS) 

31/10/2020 

2 



**CC16a Last year to the nearest £ - - - - - - - - - - 0 - 0 - 0 - - - - - - - - - - - 0 - 0 - - - - Endowment funds to nearest £ - -** 

CCXX R3 accounts (SS) 

31/10/2020 

3 



**-** OK **Endowment funds to nearest £ - - - - - - Current value (optional) - - - - - Current value (optional) - - - - - - - - - When due (optional)** 


## Date of approval 

30.10.22 

CCXX R4 accounts (SS) 

31/10/2020 

4 



CHARITY COMMISSION
FOR ENGLAND AND WALES
Independent examiner's report on the
accounts
Section A
Independent Examiner's Report
Report to the trusteesl
members of
ARRHYTHMOGENIC CARDIOMYOPATHY TRUST
On accounts for the year
ended
31 December 2021
Charity no
lif any)
1176790
I report to the trustees on my examination of the accounts of the above
charity {"the Trust.) for the year ended
Responsibilitios and
basis of report
As the charity's trL¢Stees, you are responsible for the preparation of the
accounts in accordance with the requirements of the Charities Act 2011
("the Act").
I report in respect of my examination of the Trust's accounts carried out
under section 145 of the 2011 Act and in carrying out my examination, I
have followed all the applicable Directions given by the Charity Commission
under section 145{5}{b} of the Act.
Independent I have completed my examination. I confirm that no material matters have
examlner's statement come to my attention in connection with the examination (1*•￿
d1&el￿) which gives me cause to believe that in, any material
respect..
the accounting records were not kept in accordance with section 130
of the Charities Act; or
the accounts did not accord with the accounting records., or
the accounts did not comply with the applicable requirements
concerning the form and content of accounts set out in the Charities
(Accounts and Reports) Regulalions 2008 other than any requirement
that the accounts give a 'true and fair, view which is not a matter
considered as part of an independent examination.
I have no COn￿rnS and have come across no other matters in connection
with the exarnination to which attention should be drawn in this report in
order to enable a proper understanding ofthe accounts to be reached.
Please delete the words in the brackets if they do not apply.
Slgned:
Date:
I ID.LuLI
Name:
ErMIL4 LLJU EEO¢q
Relevant professional
qualificationls) or body
lif any):
QA. (ILAEwJ)
Address:
i TtJoTlrKJ(x Ph£L
Lo rK) Oo NJ
SwJii- a%NJ
IER
Oct 2018

Section
Disclosure
Only complete if the examiner needs to highlight material matters of con￿rn
(see CC32, Independent examination of charity accounts.. directions and
guidance for examiners}.
Give here brief details of
any items that the
examiner wishes to
disclose.
IER
Oct 2018